Lo âu ở người bệnh ung thư vú điều trị tại một bệnh viện ở Hà Nội năm 2024 và một số yếu tố liên quan

Breast cancer remains a leading cause of cancer-related mortality among women worldwide, posing significant physical and psychological challenges for patients. In Vietnam, it is the most common cancer among females. Individuals undergoing breast cancer treatment often face immense distress, not only from the physical side effects and altered body image but also from profound psychological impacts such as fear of recurrence, loss of control, and overwhelming anxiety. Recognizing the high prevalence of anxiety in this patient population, understanding its determinants is crucial for enhancing holistic patient care. This study aims to assess the prevalence of anxiety among breast cancer patients receiving treatment at a hospital in Hanoi in 2024 and to identify associated factors contributing to their psychological well-being.

Healthcare professionals (oncologists, psychologists, nurses), public health researchers, and policymakers involved in cancer care and mental health services.

This cross-sectional study aimed to evaluate the prevalence of anxiety and its associated factors among breast cancer patients undergoing treatment at K Hospital Tan Trieu, Hanoi, from February to May 2024. A cohort of 405 patients was recruited using convenience sampling, with data gathered via a structured questionnaire that included the Hospital Anxiety and Depression Scale (HADS). The findings revealed that a significant proportion, 57.8%, of inpatients experienced some form of anxiety, with 31.1% exhibiting actual anxiety and 26.7% showing borderline anxiety symptoms. Multivariate regression analysis identified two primary factors independently associated with higher anxiety levels. Patients residing in rural areas were 2.82 times more likely to experience anxiety compared to those in urban areas (AOR=2.82; p<0.001). Furthermore, individuals undergoing combined treatment with two or more therapeutic methods had a 4.93-fold increased likelihood of anxiety compared to those receiving a single treatment method (AOR=4.93; p<0.01). Interestingly, factors such as education level, disease stage, and duration since diagnosis did not show a statistically significant association with anxiety. These results underscore the urgent need for regular psychological screening and mental health support for breast cancer patients, particularly those undergoing complex, multi-modal treatments and those from rural backgrounds where access to mental health services may be limited. The study recommends integrating comprehensive psychological assessments into routine oncology care to facilitate early detection and intervention for anxiety, ultimately improving the overall quality of life for these vulnerable patients.